Fiscal Year Ended Dec 31, 2024
Net sales were up 2.0% to $454.4 million compared to $445.3 million (up 3.8% in constant currency).
GAAP net income attributable to common shareholders of $7.7 million, or $0.40 per diluted share, compared to $15.1 million, or $0.77 per diluted share.
Adjusted EBITDA up 0.3% to $40.5 million compared to $40.4 million.
For complete information regarding our financials, see our periodic filings.